Oncogenes in non-small-cell lung cancer: emerging connections and novel therapeutic dynamics

作者: Giulia M Stella , Maurizio Luisetti , Ernesto Pozzi , Paolo M Comoglio

DOI: 10.1016/S2213-2600(13)70009-2

关键词:

摘要: … between key oncogenes that drive lung tumorigenesis and are … Not all genetic damage that accumulates in cancer cells during … the driving force for tumour initiation and progression. …

参考文章(98)
Malachi Griffith, Obi L. Griffith, COSMIC (Catalogue of Somatic Mutations in Cancer) Dictionary of Bioinformatics and Computational Biology. ,(2004) , 10.1002/9780471650126.DOB0851
Silvano Bosari, Fiamma Buttitta, Guido Coggi, Barbara Cassani, Massimo Roncalli, Monica Falleni, Monica Miozzo, Caterina Pellegrini, Antonio Marchetti, HER-2/Neu alterations in non-small cell lung cancer: a comprehensive evaluation by real time reverse transcription-PCR, fluorescence in situ hybridization, and immunohistochemistry. Clinical Cancer Research. ,vol. 9, pp. 3645- 3652 ,(2003)
Manel Esteller, Epigenetics in Cancer The New England Journal of Medicine. ,vol. 358, pp. 1148- 1159 ,(2008) , 10.1056/NEJMRA072067
Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber, Epidermal growth factor receptor mutations in lung cancer Nature Reviews Cancer. ,vol. 7, pp. 169- 181 ,(2007) , 10.1038/NRC2088
Edward S Kim, Roy S Herbst, Ignacio I Wistuba, J Jack Lee, George R Blumenschein Jr, Anne Tsao, David J Stewart, Marshall E Hicks, Jeremy Erasmus Jr, Sanjay Gupta, Christine M Alden, Suyu Liu, Ximing Tang, Fadlo R Khuri, Hai T Tran, Bruce E Johnson, John V Heymach, Li Mao, Frank Fossella, Merrill S Kies, Vassiliki Papadimitrakopoulou, Suzanne E Davis, Scott M Lippman, Waun K Hong, None, The BATTLE Trial: Personalizing Therapy for Lung Cancer Cancer Discovery. ,vol. 1, pp. 44- 53 ,(2011) , 10.1158/2159-8274.CD-10-0010
George J. Weiner, Monoclonal antibody mechanisms of action in cancer Immunologic Research. ,vol. 39, pp. 271- 278 ,(2007) , 10.1007/S12026-007-0073-4
Sreenath V. Sharma, Michael A. Fischbach, Daniel A. Haber, Jeffrey Settleman, “Oncogenic Shock”: Explaining Oncogene Addiction through Differential Signal Attenuation: Fig. 1. Clinical Cancer Research. ,vol. 12, pp. 4392s- 4395s ,(2006) , 10.1158/1078-0432.CCR-06-0096
Marta Puyol, Alberto Martín, Pierre Dubus, Francisca Mulero, Pilar Pizcueta, Gulfaraz Khan, Carmen Guerra, David Santamaría, Mariano Barbacid, A Synthetic Lethal Interaction between K-Ras Oncogenes and Cdk4 Unveils a Therapeutic Strategy for Non-small Cell Lung Carcinoma Cancer Cell. ,vol. 18, pp. 63- 73 ,(2010) , 10.1016/J.CCR.2010.05.025
Daniel A. Haber, Jeff Settleman, Cancer: drivers and passengers. Nature. ,vol. 446, pp. 145- 146 ,(2007) , 10.1038/446145A
Alexa B. Turke, Kreshnik Zejnullahu, Yi-Long Wu, Youngchul Song, Dora Dias-Santagata, Eugene Lifshits, Luca Toschi, Andrew Rogers, Tony Mok, Lecia Sequist, Neal I. Lindeman, Carly Murphy, Sara Akhavanfard, Beow Y. Yeap, Yun Xiao, Marzia Capelletti, A. John Iafrate, Charles Lee, James G. Christensen, Jeffrey A. Engelman, Pasi A. Jänne, Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC Cancer Cell. ,vol. 17, pp. 77- 88 ,(2010) , 10.1016/J.CCR.2009.11.022